These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7060046)
1. A pilot study of Estracyt in advanced breast cancer. Dawes PJ Cancer Treat Rep; 1982 Mar; 66(3):581-2. PubMed ID: 7060046 [No Abstract] [Full Text] [Related]
2. [Clinical evaluation of estramustine phosphate in the treatment of patients with advanced breast cancers]. Wada T; Morikawa E; Houjou T; Kadota K; Mori N; Matsunami N; Watatani M; Yasutomi M Gan To Kagaku Ryoho; 1990 Sep; 17(9):1901-4. PubMed ID: 2393306 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)]. Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487 [No Abstract] [Full Text] [Related]
4. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)]. Stridsklev IC; Fosså SD; Kaalhus O Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019 [No Abstract] [Full Text] [Related]
5. [Estracyt and radiotherapy in the treatment of prostatic cancer]. Van Regemorter G; Germeau F Acta Urol Belg; 1980 Jan; 48(1):138-48. PubMed ID: 7435350 [No Abstract] [Full Text] [Related]
6. Oral estramustine phosphate (Estracyt): a broad phase II study. Halpern J; Catane R J Med; 1984; 15(1):35-43. PubMed ID: 6593404 [TBL] [Abstract][Full Text] [Related]
7. [Total remission of prostatic cancer following treatment with Estracyt]. Romics I Orv Hetil; 1982 Jan; 123(5):287-9. PubMed ID: 7063244 [No Abstract] [Full Text] [Related]
9. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer]. Köller A; Lunglmayr G Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629 [No Abstract] [Full Text] [Related]
10. A current review of the clinical experience with Estracyt. Murphy GP Prog Clin Biol Res; 1987; 243B():221-5. PubMed ID: 3309982 [No Abstract] [Full Text] [Related]
11. [Clinical evaluation of the effectiveness of estracyt and radiation therapy in the treatment of stages II and III prostatic cancer]. Matveev BP; Figurin KM; Minakova LR; Goikhberg MI; Aslamazov EG Urol Nefrol (Mosk); 1986; (2):51-4. PubMed ID: 3521041 [No Abstract] [Full Text] [Related]
12. [Personal experience with treatment of advanced prostatic carcinoma using Estracyt]. Morávek P Rozhl Chir; 1987 Nov; 66(11):749-52. PubMed ID: 3424018 [No Abstract] [Full Text] [Related]
13. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study]. Trykker HU Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315 [No Abstract] [Full Text] [Related]
14. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt]. Németh A; Morvay J; Vécsei B Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313 [No Abstract] [Full Text] [Related]
15. Estracyt--mode of action and clinical experience. Hedlund PO Prog Clin Biol Res; 1987; 243B():215-9. PubMed ID: 3309981 [No Abstract] [Full Text] [Related]
16. Pilot study on the growth inhibition by estramustine phosphate (Estracyt) of rat mammary tumours sensitive and insensitive of oestrogen. Müntzing J; Jensen G; Högberg B Acta Pharmacol Toxicol (Copenh); 1979 Jan; 44(1):1-6. PubMed ID: 104546 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)]. Rambausek M; Lutherer S; Terhorst B Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632 [TBL] [Abstract][Full Text] [Related]
18. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate. Edsmyr F; Esposti PL; Andersson L Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017 [TBL] [Abstract][Full Text] [Related]
19. Cancer of the prostate. Treating metastasis with estramustine phosphate. Hoeft RT; Jones AG Am J Nurs; 1982 May; 82(5):829-30. PubMed ID: 6918193 [No Abstract] [Full Text] [Related]